DarioHealth Corp. (DRIO)
NASDAQ: DRIO · IEX Real-Time Price · USD
1.570
+0.070 (4.67%)
At close: May 3, 2024, 4:00 PM
1.510
-0.060 (-3.82%)
After-hours: May 3, 2024, 5:09 PM EDT
DarioHealth Revenue
In the year 2023, DarioHealth had annual revenue of $20.35M, a decrease of -26.41%. Revenue in the quarter ending December 31, 2023 was $3.62M, a -46.89% decrease year-over-year.
Revenue (ttm)
$20.35M
Revenue Growth
-26.41%
P/S Ratio
2.27
Revenue / Employee
$73,739
Employees
276
Market Cap
46.22M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 20.35M | -7.30M | -26.41% |
Dec 31, 2022 | 27.66M | 7.14M | 34.82% |
Dec 31, 2021 | 20.51M | 12.94M | 170.76% |
Dec 31, 2020 | 7.58M | 17.00K | 0.22% |
Dec 31, 2019 | 7.56M | 165.00K | 2.23% |
Dec 31, 2018 | 7.39M | 2.22M | 43.02% |
Dec 31, 2017 | 5.17M | 2.37M | 84.45% |
Dec 31, 2016 | 2.80M | 1.98M | 240.58% |
Dec 31, 2015 | 823.00K | 772.00K | 1,513.73% |
Dec 31, 2014 | 51.00K | - | - |
Dec 31, 2013 | 0 | - | - |
Dec 31, 2012 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Nortech Systems | 139.33M |
Cytosorbents | 36.35M |
Ocuphire Pharma | 19.05M |
Dyadic International | 2.90M |
Lucid Diagnostics | 2.43M |
Renalytix | 2.41M |
Matinas BioPharma Holdings | 1.10M |
DRIO News
- 8 days ago - Dario Publishes New Peer-Reviewed Study that Deepens the Body of Evidence that Managing Cardiometabolic Conditions in One Integrated Platform Improves Clinical Outcomes - PRNewsWire
- 15 days ago - Dario Signs Two Employers for Cardiometabolic Suite with Integrated GLP-1 Solution - PRNewsWire
- 23 days ago - Dario Publishes Two New Peer-Reviewed Studies Demonstrating Impact of Digital Behavioral Health - PRNewsWire
- 4 weeks ago - Two National Employers Select Dario's Integrated Chronic Condition Solution to Improve Employee Health - PRNewsWire
- 5 weeks ago - DarioHealth Reports Fourth Quarter and Full-Year 2023 Financial and Operating Results - PRNewsWire
- 6 weeks ago - DARIOHEALTH TO REPORT FOURTH QUARTER 2023 RESULTS ON THURSDAY, MARCH 28TH - PRNewsWire
- 7 weeks ago - New Research from Dario Demonstrates Ability to Deliver Improved Health Outcomes with Integrated Solution for Members Managing Weight and Blood Glucose with or without GLP-1 Medications - PRNewsWire
- 2 months ago - DARIOHEALTH TO PARTICIPATE IN THE COWEN 43RD ANNUAL HEALTHCARE CONFERENCE - PRNewsWire